Caris Life Sciences, Inc. Common Stock

Stock Chart, Company Information, and Scan Results

$18.81(as of Mar 19, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Caris Life Sciences, Inc. Common Stock Company Information, Fundamentals, and Technical Indicators

Stock Price$18.81
Ticker SymbolCAI
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees1,846
CountyUSA
Market Cap$5,219.3M
EBIDTA67.7M
10-Day Moving Average18.55
P/E Ratio-461.92
20-Day Moving Average18.88
Forward P/E Ratio34.84
50-Day Moving Average22.12
Earnings per Share-3.22
200-Day Moving Average27.76
Profit Margin27.98%
RSI43.15
Shares Outstanding282.6M
ATR1.16
52-Week High42.50
Volume3,268,465
52-Week Low17.15
Most Recent Support Level17.85
Book Value577.3M
Most Recent Resistance Level19.65
P/B Ratio54.48
Upper Keltner21.49
P/S Ratio38.73
Lower Keltner16.27
Debt-to-Equity Ratio21.49
Next Earnings DateUnknown
Cash Surplus670.7M
Next Ex-Dividend DateUnknown

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and artificial intelligence/machine learning algorithms. The company's molecular intelligence product portfolio includes MI Profile Platform, a whole exome sequencing (WES)/ whole transcriptome sequencing (WTS) tissue-based molecular profiling solutions; Caris Assure Platform WES/WTS blood-based molecular profiling solutions; Precision Whole Genome Platform, a whole genome sequencing (WGS) blood- and tissue-based profiling solutions; and Caris Detect, a WGS-based multi-cancer early detection solution; Caris WGS MRD a WGS and digital droplet polymerase reaction-based minimal residual disease solution; and Caris ChromoSeq, a WGS and WTS based assay for therapy selection in hematological cancers. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company provides its precision oncology solutions to customers, such as hospitals, institutions and patients. The company was founded in 2008 and is headquartered in Irving, Texas.

Caris Life Sciences, Inc. Common Stock In Our Stock Scanner

As of Mar 20, 2026
example chart graphic
Scan Name: Double BottomScan Type: Chart Pattern Scans
As of ---
example chart graphic
Scan Name: Heikin Ashi BreakoutScan Type: Candlestick Pattern Scans
As of ---
example chart graphic
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.